Share This Page
Drug Price Trends for MULTIVIT-IRON-FL
✉ Email this page to a colleague
Average Pharmacy Cost for MULTIVIT-IRON-FL
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| MULTIVIT-IRON-FLUOR 0.25 MG/ML | 61269-0163-50 | 0.19536 | ML | 2025-06-18 |
| MULTIVIT-IRON-FLUOR 0.25 MG/ML | 61269-0163-50 | 0.19484 | ML | 2025-05-21 |
| MULTIVIT-IRON-FLUOR 0.25 MG/ML | 61269-0163-50 | 0.19767 | ML | 2025-04-23 |
| MULTIVIT-IRON-FLUOR 0.25 MG/ML | 61269-0163-50 | 0.20033 | ML | 2025-03-19 |
| MULTIVIT-IRON-FLUOR 0.25 MG/ML | 61269-0163-50 | 0.20335 | ML | 2025-02-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Multivitamins with Iron
Introduction to Multivitamins with Iron
Multivitamins with iron are dietary supplements designed to address nutritional deficiencies, particularly iron deficiency and anemia. These supplements are essential for various bodily functions, including oxygen transport, energy metabolism, and DNA synthesis.
Global Market Overview
The global market for iron supplements, which includes multivitamins with iron, is growing steadily due to several key factors.
-
Prevalence of Iron Deficiency: The high prevalence of iron deficiency and anemia worldwide is a significant driver for the market. According to market research, the global iron supplements market was valued at USD 6,218.5 million in 2023 and is expected to reach USD 9,293.8 million by 2033, growing at a CAGR of 4.1% from 2024 to 2033[3].
-
Rising Health Awareness: Increasing awareness about the importance of iron in maintaining overall health and preventing anemia contributes to market growth. Individuals are seeking preventive healthcare measures and dietary supplements, driving the demand for multivitamins with iron[3].
Market Segmentation
By Type of Iron Supplement
The market for iron supplements, including multivitamins with iron, can be segmented by the type of iron used. Common types include:
- Iron Dextran
- Iron Sucrose
- Ferric Carboxymaltose (FCM)
- Others
FCM has emerged as a leading segment due to its effectiveness, safety, and cost-efficiency. It is preferred for its high-dose iron replenishment capabilities and is used for treating various forms of anemia[1][4].
By Application
Multivitamins with iron are used in various applications:
- Chronic Kidney Disease (CKD)
- Inflammatory Bowel Disease (IBD)
- Cancer
- Other Diseases
The CKD segment accounts for a significant revenue share due to the frequent need for iron therapy in patients with CKD[1][4].
Regional Market Analysis
North America
North America holds the largest market share for intravenous iron drugs and is expected to continue its dominance. The U.S. market is driven by the increasing prevalence of anemia, with over 3 million people affected, and the approval of new IV iron drugs such as INJECTAFER for specific conditions like heart failure[1][4].
Europe
Europe is the second-largest market, driven by factors such as the presence of major market players, the development and commercialization of new drugs, and the rising incidence of cancer. Germany dominates the regional market due to high healthcare expenditures and the high prevalence of cancer[1].
Asia Pacific
The Asia Pacific region is expected to witness the fastest growth due to the increasing prevalence of chronic diseases like CKD, IBD, and cancer, which frequently result in iron deficiency anemia (IDA)[1][4].
Latin America
Latin America, particularly countries like Brazil and Mexico, is identified as a lucrative region. The dynamic economies, R&D activities, and rapid technological advancements in these countries are expected to drive market growth[1].
Price Projections and Trends
Current Pricing
The cost for multivitamins with iron can vary based on the formulation and brand. For example, a multivitamin with iron and fluoride oral liquid can cost around $15.90 for a 50-milliliter supply[2].
Future Pricing Trends
The market for iron supplements, including multivitamins with iron, is expected to grow steadily. However, pricing trends may be influenced by several factors:
- Technological Advancements: Innovations in drug delivery systems, such as nanoparticle-based formulations, could enhance the efficacy and reduce the cost of these supplements[1].
- Regulatory Approvals: New product launches and approvals, such as the FDA approval of INJECTAFER, can impact pricing by increasing competition and driving down costs[1][4].
- Market Competition: The entry of new players and the expansion of existing ones can lead to competitive pricing strategies, potentially reducing the cost of multivitamins with iron[3].
Key Drivers and Challenges
Drivers
- Increasing Prevalence of Chronic Diseases: The growing prevalence of CKD, IBD, and cancer drives the demand for effective anemia management solutions, including multivitamins with iron[1][4].
- Advancements in Technology: Improvements in drug delivery systems and the development of biocompatible materials enhance the precision and reliability of iron therapy administration[1].
- Regulatory Approvals: New product approvals and launches are critical for market expansion and can drive growth by providing more treatment options[1][4].
Challenges
- Side Effects and Adverse Reactions: Despite advancements, some iron supplements can have side effects, which may deter some consumers. However, formulations like FCM have shown superior performance with fewer adverse effects[1].
- Economic Factors: The cost of these supplements can be a barrier for some consumers, especially in regions with lower healthcare expenditures[2].
Expert Insights and Statistics
- Ferric Carboxymaltose (FCM) Efficacy: FCM has been proven to be safer and more effective compared to other IV iron drugs. For instance, a report published by NCBI in June 2022 highlighted that FCM can treat moderate-to-severe anemia in around 4 weeks[1].
<blockquote>
"FCM has greater efficacy with respect to improving hemoglobin levels and results in limited adverse events." - NCBI Report, June 2022[1].
</blockquote>- Market Growth Statistics: The global intravenous iron drugs market, which includes multivitamins with iron, is expected to grow at a CAGR of 9.2% from 2024 to 2030, reaching USD 5.62 billion by 2030[1].
Key Takeaways
- The global market for iron supplements, including multivitamins with iron, is driven by the increasing prevalence of chronic diseases and advancements in technology.
- Ferric carboxymaltose (FCM) is a leading segment due to its safety and efficacy.
- North America and Europe are significant markets, with the Asia Pacific region expected to grow the fastest.
- Pricing trends will be influenced by technological advancements, regulatory approvals, and market competition.
Frequently Asked Questions (FAQs)
1. What is the current market size for intravenous iron drugs? The global intravenous iron drugs market size was estimated at USD 3.03 billion in 2023[1].
2. What is the expected growth rate for the intravenous iron drugs market? The market is expected to grow at a CAGR of 9.2% from 2024 to 2030[1].
3. Which region dominates the intravenous iron drugs market? North America holds the largest market share, primarily due to the increasing approvals and launch of new IV drugs in the U.S.[1].
4. What are the key applications of multivitamins with iron? Key applications include treating chronic kidney disease, inflammatory bowel disease, cancer, and other diseases[1][4].
5. How does ferric carboxymaltose (FCM) compare to other IV iron drugs? FCM has greater efficacy in improving hemoglobin levels and results in limited adverse events, making it a safer and more effective option[1].
More… ↓
